Moderna Inc (MRNA)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Gross profit (ttm) US$ in thousands -390,000 1,672,000 4,543,000 8,419,000 12,435,000 15,793,000 17,886,000 18,212,000 15,098,000 9,710,764 5,740,765 2,287,382 604,584 136,875 16,732 -28,325 -23,785 -2,419
Revenue (ttm) US$ in thousands 6,758,000 9,088,000 10,654,000 15,059,000 19,263,000 21,390,000 22,995,000 22,600,000 18,471,000 11,831,000 7,019,000 2,732,000 803,000 246,055 106,101 52,184 60,209 81,575
Gross profit margin -5.77% 18.40% 42.64% 55.91% 64.55% 73.83% 77.78% 80.58% 81.74% 82.08% 81.79% 83.73% 75.29% 55.63% 15.77% -54.28% -39.50% -2.97%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $-390,000K ÷ $6,758,000K
= -5.77%

The gross profit margin of Moderna Inc has displayed a decreasing trend over the past eight quarters. Starting at a high level of 84.77% in Q1 2022, the margin has steadily declined to 31.47% in Q4 2023. This suggests that Moderna Inc's cost of goods sold has been increasing relative to its revenue generation. The significant drop in the gross profit margin from Q1 2022 to Q4 2023 indicates a potential challenge in maintaining profitability and cost efficiency in the company's operations. Further analysis into the factors influencing these changes would be necessary to understand the underlying causes and implications for Moderna Inc's financial performance.


Peer comparison

Dec 31, 2023


See also:

Moderna Inc Gross Profit Margin (Quarterly Data)